RESEARCH-USE BIOSIMILAR ANTIBODY
Tilogotamab
Monoclonal antibody · IgG1
Tilogotamab is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM).
TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-117
CATALOG NUMBERSC-BS-117
MOLECULAR WEIGHTApprox. 144.88 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tilogotamab is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM).
Tilogotamab is a recombinant research-use antibody directed against TNFRSF10B.